Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1991-6-7
|
pubmed:abstractText |
Female Uje: WIST rats received thioacetamide (TAA) in the tap water (0.3 g/l) from the 4th to 6th months of life to produce experimental liver cirrhosis. Immediately, 2 and 7 days after TAA cessation it was investigated by means of in vivo (caffeine and metamizol elimination) and vitro methods (cytochrome P-450, 7-ethoxycoumarin and 7-ethoxyresorufin O-deethylation), whether this animal model represents the restricted cytochrome P-450-dependent biotransformation comparable to human liver cirrhosis. The total capacity of the liver was diminished immediately and 2 days after TAA cessation. After 7 days the capacity was unchanged compared to the controls or partly even enhanced. Therefore, this animal model reflects rather a short time than a stable alteration of biotransformation after TAA cessation comparable to human liver cirrhosis.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0863-1743
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
190-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2091675-Animals,
pubmed-meshheading:2091675-Biotransformation,
pubmed-meshheading:2091675-Caffeine,
pubmed-meshheading:2091675-Cytochrome P-450 Enzyme System,
pubmed-meshheading:2091675-Dipyrone,
pubmed-meshheading:2091675-Female,
pubmed-meshheading:2091675-Liver,
pubmed-meshheading:2091675-Liver Regeneration,
pubmed-meshheading:2091675-Metabolic Clearance Rate,
pubmed-meshheading:2091675-Organ Size,
pubmed-meshheading:2091675-Rats,
pubmed-meshheading:2091675-Rats, Inbred Strains,
pubmed-meshheading:2091675-Thioacetamide
|
pubmed:year |
1990
|
pubmed:articleTitle |
[Effect of 3 months of thioacetamide treatment on liver biotransformation in vivo and in vitro (various times after discontinuation)].
|
pubmed:affiliation |
Institut für Klinische Pharmakologie, Friedrich-Schiller-Universität Jena.
|
pubmed:publicationType |
Journal Article,
English Abstract
|